Add to Favourites
To login click here

The use of microRNAs as biomarkers for early cancer detection has shown great potential, with particular miRNA signatures being able to accurately diagnose difficult-to-detect cancers. Technological advances in biosensor development and machine learning have aided in the identification and clinical validation of these miRNA signatures.